Target
non-AR
1 abstract
Abstract
Transcriptomic heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer.Org: Veracyte, Inc., Ghent University Hospital, Northwestern University Feinberg School of Medicine, Helen Diller Family Comprehensive Cancer Center, Oncology Institute of Southern Switzerland,